Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5726)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2022 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Devan AR, Pavithran K, Nair B, Murali M, Nath LR. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma. World J Gastroenterol 2022; 28(36): 5250-5264 [PMID: PMC9521521 DOI: 10.3748/wjg.v28.i36.5250] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i36/5250.htm |
| Number | Citing Articles |
| 1 |
Haiyan Chen, Huimin Zhou, Bo Wu, Hanxiao Lu, Jie Zhang, Yan Zhang, Yuanlong Gu, Guangwen Zhou, Jie Xiang, Jun Yang. Physical activity and exercise in liver cancer. Liver Research 2024; 8(1): 22 doi: 10.1016/j.livres.2024.03.001
|
| 2 |
Yosuke Murata, Takuto Nosaka, Yu Akazawa, Tomoko Tanaka, Kazuto Takahashi, Tatsushi Naito, Hidetaka Matsuda, Masahiro Ohtani, Yasunari Nakamoto. Serial Changes of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab. Cancers 2024; 16(13): 2410 doi: 10.3390/cancers16132410
|
| 3 |
Vishal Kumar Deb, Nidhi Chauhan, Utkarsh Jain. Deciphering TGF-β1's role in drug resistance and leveraging plant bioactives for cancer therapy. European Journal of Pharmacology 2025; 988: 177218 doi: 10.1016/j.ejphar.2024.177218
|
| 4 |
Xiaoyan Jin, Jing Zhang, Yufu Zhang, Jing He, Mingming Wang, Yu Hei, Shutong Guo, Xiangrong Xu, Yusi Liu. Different origin-derived exosomes and their clinical advantages in cancer therapy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1401852
|
| 5 |
Reza Arefnezhad, Sara Ashna, Fatemeh Rezaei‐Tazangi, Seyed Mahdi Arfazadeh, Seyede Shabnam Seyedsalehie, Shaghayegh Yeganeafrouz, Melika Aghaei, Mandana Sanandaji, Ramin Davoodi, Sareh Ranjbar Karim Abadi, Massoud Vosough. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate. Cell Biology International 2024; 48(5): 556 doi: 10.1002/cbin.12145
|
| 6 |
Lihui Liu, Daqing Jiang, Shi Bai, Xinfeng Zhang, Yue Kang. Research progress of exosomes in drug resistance of breast cancer. Frontiers in Bioengineering and Biotechnology 2024; 11 doi: 10.3389/fbioe.2023.1214648
|
| 7 |
Cornelia Tolg, Kathleen Allen Hill, Eva Ann Turley. CD44 and RHAMM Are Microenvironmental Sensors with Dual Metastasis Promoter and Suppressor Functions. Advanced Biology 2024; 8(6) doi: 10.1002/adbi.202300693
|
| 8 |
Shaza Issa, Haidar Fayoud, Alisa Shaimardanova, Albert Sufianov, Galina Sufianova, Valeriya Solovyeva, Albert Rizvanov. Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases. Biomedicines 2024; 12(8): 1906 doi: 10.3390/biomedicines12081906
|
| 9 |
Chaowen Xiao, Xinyang Zhao, Zouxiao Hu, Guanbao Long. MFSD2A Overexpression Inhibits Hepatocellular Carcinoma Through TGF‐β/Smad Signaling. Molecular Carcinogenesis 2025; 64(3): 597 doi: 10.1002/mc.23875
|
| 10 |
Lorenza Di Marco, Adriana Romanzi, Alessandra Pivetti, Nicola De Maria, Federico Ravaioli, Massimiliano Salati, Erica Villa, Fabrizio Di Benedetto, Paolo Magistri, Massimo Dominici, Antonio Colecchia, Stefano Di Sandro, Andrea Spallanzani. Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation. Critical Reviews in Oncology/Hematology 2025; 207: 104607 doi: 10.1016/j.critrevonc.2024.104607
|
| 11 |
Gopika Chandrababu, Merlin Varkey, Aswathy R. Devan, M. V. Anjaly, Ashok R. Unni, Lekshmi R. Nath. Kaempferide exhibits an anticancer effect against hepatocellular carcinoma in vitro and in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(10): 2461 doi: 10.1007/s00210-023-02468-8
|
| 12 |
Yucong Ma, Suping Ye, Kunpeng Sun, Yue Gu. Effect of curcumin nanoparticles on proliferation and migration of mouse airway smooth muscle cells and airway inflammatory infiltration. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1344333
|
| 13 |
Aswathy R. Devan, Bhagyalakshmi Nair, Manu Kanjoormana Aryan, Vijayastelar B. Liju, Joel Joy Koshy, Bijo Mathew, Arun Valsan, Hoon Kim, Lekshmi R. Nath. Decoding Immune Signature to Detect the Risk for Early-Stage HCC Recurrence. Cancers 2023; 15(10): 2729 doi: 10.3390/cancers15102729
|
| 14 |
Weiwei Yuan, Yuanmin Xu, Zhiheng Wu, Yang Huang, Lei Meng, Shiping Dai, Songcheng Ying, Zhangming Chen, Aman Xu. Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11288-1
|
| 15 |
Rachel Si-Yin Wong, Timothy Tan, Alexander Shao-Rong Pang, Dinesh Kumar Srinivasan. The role of cytokines in wound healing: from mechanistic insights to therapeutic applications. Exploration of Immunology 2025; 5 doi: 10.37349/ei.2025.1003183
|
| 16 |
Ángel M. Cuesta, Nerea Palao, Paloma Bragado, Alvaro Gutierrez-Uzquiza, Blanca Herrera, Aránzazu Sánchez, Almudena Porras. New and Old Key Players in Liver Cancer. International Journal of Molecular Sciences 2023; 24(24): 17152 doi: 10.3390/ijms242417152
|
| 17 |
Pankaj Garg, Siddhika Pareek, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Exploring the potential of TGFβ as a diagnostic marker and therapeutic target against cancer. Biochemical Pharmacology 2025; 231: 116646 doi: 10.1016/j.bcp.2024.116646
|
| 18 |
Jie Chen, Chao Ji, Silin Liu, Jin Wang, Che Wang, Jue Pan, Jinyu Qiao, Yu Liang, Mengjiao Cai, Jinlu Ma. Transforming growth factor-β (TGF-β) signaling pathway-related genes in predicting the prognosis of colon cancer and guiding immunotherapy. Cancer Pathogenesis and Therapy 2024; 2(4): 299 doi: 10.1016/j.cpt.2023.12.002
|